SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

BRIEF-Bio-Thera Solutions Gets Regulatory Approval For Clinical Trial On COVID Treatment

reuters.com · 06/10/2022 05:06
BRIEF-Bio-Thera Solutions Gets Regulatory Approval For Clinical Trial On COVID Treatment

- Bio-Thera Solutions Ltd 688177.SS:

  • SAYS IT GETS CHINESE MEDICINE REGULATOR'S APPROVAL FOR CLINICAL TRIAL ON ITS BAT2022 FOR COVID TREATMENT

Source text

Further company coverage: 688177.SS


(Reporting by Hong Kong newsroom)

((meg.shen@thomsonreuters.com; 852-39525805;))